Theranos and its founder Elizabeth Holmes charged with 'massive fraud'

Federal agency calls disgraced firm, which allegedly deceived investors of $700m, ‘an important lesson for Silicon Valley’

The Silicon Valley startup Theranos and its chief executive Elizabeth Holmes were charged by the Securities and Exchange Commission (SEC) on Wednesday with “massive fraud” for raising $700m from investors by allegedly deceiving them about their supposedly groundbreaking blood-testing technology.

Theranos and Holmes agreed to settle the charges without admitting or denying wrongdoing. Holmes, a Stanford dropout who was once hailed as the next Steve Jobs, will pay a $500,000 penalty, return millions of shares to the company, and relinquish her company voting power under the terms of the settlement. She will also be barred for 10 years from serving as an officer or director of a public company.

“The Theranos story is an important lesson for Silicon Valley,” Jina Choi, the director of the SEC’s San Francisco office, said in a statement. “Innovators who seek to revolutionize and disrupt an industry must tell investors the truth about what their technology can do today, not just what they hope it might do someday.”

The settlement bookends an ignominious tale of Silicon Valley excess.

Holmes founded Theranos in 2003 with the goal of revolutionizing blood testing. The company received glowing press coverage and raised more than $700m from investors based on its promise that it had invented a machine that could conduct hundreds of laboratory tests with a single finger prick of blood.

But in 2015, a series of Wall Street Journal articles revealed the company’s technology to be more of a parlor trick than a medical miracle. Most of the tests Theranos claimed to perform on its Edison machines were actually being performed by traditional blood-testing machines bought from other companies, the Journal revealed. Regulators subsequently raised serious concerns about the accuracy of testing that Theranos did conduct with its machines, and the company eventually retracted two years of blood tests.

Theranos initially defended its technology, but subsequently agreed to shut down its labs and testing centers. In 2016, Holmes was barred from running a lab for two years by regulators. Theranos has settled lawsuits with an investor and Walgreens.

“The company is pleased to be bringing this matter to a close and looks forward to advancing its technology,” Theranos’s independent directors said in a statement.

The SEC complaint provides an inside look at how Holmes and Theranos enticed investors. The company would stage a blood test for potential investors, with phlebotomists actually taking a finger prick of their blood, despite the fact that the company’s machines were not being used to perform the tests.

The complaint also details how Holmes fooled the media into overstating the capabilities of the technology, then used that coverage to raise funds.

Holmes allegedly falsely told investors that Theranos’ machines were being used by the US defense department on the battlefield in Afghanistan and that the company would bring in $100m in revenue in 2014.

Theranos’ actual 2014 revenues were approximately $100,000. The SEC also charged the company’s former president Ramesh Balwani, who left Theranos in 2016. He has not agreed to a settlement, so the charges against him will be litigated in federal court.


Julia Carrie Wong in San Francisco

The GuardianTramp

Related Content

Article image
Theranos founder Elizabeth Holmes charged with criminal fraud
Ramesh Balwani, former president of blood-testing startup, also charged and
pair appear in federal court hours after Holmes quits as CEO

Olivia Solon in San Francisco

15, Jun, 2018 @10:13 PM

Article image
Elizabeth Holmes trial: jury finds Theranos founder guilty on four fraud counts
The jury delivered the verdict after announcing they were deadlocked on three of the 11 charges Holmes faced

Kari Paul

04, Jan, 2022 @10:23 AM

Article image
Theranos founder Elizabeth Holmes testifies at trial in risky move
The former CEO testified about the early days of setting up her company in surprise decision by her defense team

Kari Paul

20, Nov, 2021 @1:15 AM

Article image
Elizabeth Holmes trial: jury to begin deliberations in Theranos founder’s case
Former CEO faces a maximum of 20 years in prison on nine counts of fraud and two counts of conspiracy to commit fraud

Kari Paul in San Jose

18, Dec, 2021 @1:58 AM

Article image
Elizabeth Holmes to be sentenced this week as Theranos saga nears conclusion
The blood testing company’s founder could serve up to 20 years in prison after she was convicted in January on four counts of fraud

Kari Paul in San Francisco

14, Nov, 2022 @11:00 AM

Article image
Elizabeth Holmes looms large on first day of Sunny Balwani’s Theranos trial
Prosecutors portray ex-executive as accomplice in a health scam while defense paints picture of well-meaning businessman

Guardian staff and agencies

22, Mar, 2022 @11:11 PM

Article image
Theranos could be banned from running labs for two years, regulators warn
Blood-testing startup accused of not resolving issues found during inspection earlier this year that created ‘immediate jeopardy to patient health and safety’

Jemima Kiss in San Francisco

13, Apr, 2016 @7:46 PM

Article image
Disgraced Theranos founder Elizabeth Holmes' trial could be delayed by pregnancy
Holmes is on trial for allegedly defrauding investors, doctors and patients while at the helm of blood-testing startup

Kari Paul and agencies

13, Mar, 2021 @2:13 AM

Article image
Theranos lab chief says Elizabeth Holmes offered ‘implausible’ explanation for odd findings
Kingshuk Das testifies that former CEO was resistant to critiques of company’s devices

Kari Paul in San Jose

10, Nov, 2021 @5:30 AM

Article image
Theranos founder Elizabeth Holmes sentenced to more than 11 years for defrauding investors
The harsh ruling sends a message to Silicon Valley that the government will hold founders accountable for what’s promised

Kari Paul in San Jose, California

18, Nov, 2022 @10:41 PM